How should access to antiretroviral treatment be measured?
Main Authors: | Leigh F Johnson, Andrew Boulle |
---|---|
Format: | Article |
Language: | English |
Published: |
The World Health Organization
2011-02-01
|
Series: | Bulletin of the World Health Organization |
Online Access: | http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862011000200016 |
Similar Items
-
How should access to antiretroviral treatment be measured?
by: Leigh F Johnson, et al. -
Associations with virologic treatment failure in adults on antiretroviral therapy in South Africa.
by: Datay, M, et al.
Published: (2010) -
Can routine antenatal data be used to assess HIV antiretroviral therapy coverage among pregnant women? Evaluating the validity of different data sources in the Western Cape, South Africa.
by: Nisha Jacob, et al.
Published: (2024-01-01) - New coalition for access to antiretrovirals
-
How soon should patients be eligible for differentiated service delivery models for antiretroviral treatment? Evidence from a retrospective cohort study in Zambia
by: Anna Grimsrud, et al.
Published: (2022-12-01)